Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics

Otyepka M, Bártová I, Kríz Z, Koca

. 2006 ; 281 (11) : 7271-7281.

Language English Country United States

A detailed analysis is presented of the dynamics of human CDK5 in complexes with the protein activator p25 and the purine-like inhibitor roscovitine. These and other findings related to the activation of CDK5 are critically reviewed from a molecular perspective. In addition, the results obtained on the behavior of CDK5 are compared with data on CDK2 to assess the differences and similarities between the two kinases in terms of (i) roscovitine binding, (ii) regulatory subunit association, (iii) conformational changes in the T-loop following CDK/regulatory subunit complex formation, and (iv) specificity in CDK/regulatory subunit recognition. An energy decomposition analysis, used for these purposes, revealed why the binding of p25 alone is sufficient to stabilize the extended active T-loop conformation of CDK5, whereas the equivalent conformational change in CDK2 requires both the binding of cyclin A and phosphorylation of the Thr(160) residue. The interaction energy of the CDK5 T-loop with p25 is about 26 kcal.mol(-1) greater than that of the CDK2 T-loop with cyclin A. The binding pattern between CDK5 and p25 was compared with that of CDK2/cyclin A to find specific regions involved in CDK/regulatory subunit recognition. The analyses performed revealed that the alphaNT-helix of cyclin A interacts with the alpha6-alpha7 loop and the alpha7 helix of CDK2, but these regions do not interact in the CDK5/p25 complex. Further differences between the CDK5/p25 and CDK2/cyclin A systems studied are discussed with respect to their specific functionality.

000      
00000naa 2200000 a 4500
001      
bmc07520526
003      
CZ-PrNML
005      
20111210131148.0
008      
090403s2006 xxu e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Otyepka, Michal, $d 1975- $7 mzk2004257598
245    10
$a Different mechanisms of CDK5 and CDK2 activation as revealed by CDK5/p25 and CDK2/cyclin A dynamics / $c Otyepka M, Bártová I, Kríz Z, Koca
314    __
$a Department of Physical Chemistry and Center for Biomolecules and Complex Molecular Systems, Palacký University, tr. Svobody 26, 771 46 Olomouc, Czech Republic. otyepka@aix.upol.cz
520    9_
$a A detailed analysis is presented of the dynamics of human CDK5 in complexes with the protein activator p25 and the purine-like inhibitor roscovitine. These and other findings related to the activation of CDK5 are critically reviewed from a molecular perspective. In addition, the results obtained on the behavior of CDK5 are compared with data on CDK2 to assess the differences and similarities between the two kinases in terms of (i) roscovitine binding, (ii) regulatory subunit association, (iii) conformational changes in the T-loop following CDK/regulatory subunit complex formation, and (iv) specificity in CDK/regulatory subunit recognition. An energy decomposition analysis, used for these purposes, revealed why the binding of p25 alone is sufficient to stabilize the extended active T-loop conformation of CDK5, whereas the equivalent conformational change in CDK2 requires both the binding of cyclin A and phosphorylation of the Thr(160) residue. The interaction energy of the CDK5 T-loop with p25 is about 26 kcal.mol(-1) greater than that of the CDK2 T-loop with cyclin A. The binding pattern between CDK5 and p25 was compared with that of CDK2/cyclin A to find specific regions involved in CDK/regulatory subunit recognition. The analyses performed revealed that the alphaNT-helix of cyclin A interacts with the alpha6-alpha7 loop and the alpha7 helix of CDK2, but these regions do not interact in the CDK5/p25 complex. Further differences between the CDK5/p25 and CDK2/cyclin A systems studied are discussed with respect to their specific functionality.
650    _2
$a proteiny buněčného cyklu $x chemie $7 D018797
650    _2
$a cyklin A $x chemie $x metabolismus $7 D019925
650    _2
$a cyklin-dependentní kinasa 2 $x metabolismus $7 D051357
650    _2
$a cyklin-dependentní kinasa 5 $x metabolismus $7 D051360
650    _2
$a lidé $7 D006801
650    _2
$a vodíková vazba $7 D006860
650    _2
$a chemické modely $7 D008956
650    _2
$a molekulární modely $7 D008958
650    _2
$a molekulární konformace $7 D008968
650    _2
$a proteiny nervové tkáně $x metabolismus $7 D009419
650    _2
$a fosforylace $7 D010766
650    _2
$a fylogeneze $7 D010802
650    _2
$a konformace proteinů $7 D011487
650    _2
$a inhibitory proteinkinas $x farmakologie $x chemie $7 D047428
650    _2
$a sekundární struktura proteinů $7 D017433
650    _2
$a terciární struktura proteinů $7 D017434
650    _2
$a puriny $x farmakologie $x chemie $7 D011687
650    _2
$a stereoizomerie $7 D013237
650    _2
$a substrátová specifita $7 D013379
650    _2
$a threonin $x chemie $7 D013912
650    _2
$a tyrosin $x chemie $7 D014443
650    _2
$a financování organizované $7 D005381
700    1_
$a Bártová, Iveta $7 xx0098557
700    1_
$a Kříž, Zdeněk $7 xx0068636
700    1_
$a Koča, Jaroslav, $d 1955-2021 $7 jn20000710314
773    0_
$w MED00002546 $t The journal of biological chemistry $g Roč. 281, č. 11 (2006), s. 7271-7281 $x 0021-9258
910    __
$a ABA008 $b x $y 9
990    __
$a 20090312170439 $b ABA008
991    __
$a 20090717105849 $b ABA008
999    __
$a ok $b bmc $g 638329 $s 491128
BAS    __
$a 3
BMC    __
$a 2006 $b 281 $c 11 $d 7271-7281 $i 0021-9258 $m The Journal of biological chemistry $x MED00002546
LZP    __
$a 2009-B1/vtme

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...